Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Clinical trial NCT04805307 · COMPLETED

Trial details

NCT number: NCT04805307
Sponsor: Keymed Biosciences Co.Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Gastric Cancer(Including Gastroesophageal Junction Adenocarcinoma)Pancreatic Cancer

Start date: 2020-12-24
Primary completion: 2024-04-05
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.